Piper Sandler Upgrades Medtronic to Overweight, Raises Price Target to $120
Benzinga Newsdesk 5 days ago
Analyst RatingsNewsUpgradesPrice TargetHot
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Piper Sandler analyst Matt O'Brien upgrades Medtronic (NYSE:MDT) from Neutral to Overweight and raises the price target from $85 to $120.
Piper Sandler analyst Matt O'Brien upgrades Medtronic (NYSE:MDT) from Neutral to Overweight and raises the price target from $85 to $120.
